Individualización del tratamiento en Adenocarcinoma de pulmón tras la primera línea de quimioterapia

•

Nintedanib inhibits all types of three key RTKs involved in

angiogenesis*

–

VEGFRs,

–

PDGFRs and

–

FGFRs

VEGFR=vascular endothelial growth factor receptor;

PDGFR=platelet-derived growth factor receptor; FGFR=fibroblast

growth factor receptor

*Hilberg F, et al.

Cancer Res

2008;68:4774–4782

Nintedanib: inhibidor triple angioquinasa